Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ content in young adults with acute myocardial infarction. Evaluation at the initial stage and after 12 months

Clinical Hemorheology and Microcirculation

Volumn 31, Issue 1, 2004, Pages 41-47

  Caimi, G ^a,b   Hoffmann, E ^a   Canino, B ^a   Montana, M ^a   Dispensa, F ^a   Incalcaterra, E ^a   Casciolo, M F ^a   Catania, A ^a   Lo Presti, R ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Acute myocardial infarction in young people; Polymorphonuclear leukocyte activation; Polymorphonuclear leukocyte Ca2+ content; Polymorphonuclear leukocyte membrane fluidity

Indexed keywords

1,4 TRIMETHYLAMINO PHENYL 4 PHENYLHEXATRIENE; 4 PHORBOL 12 MYRISTATE 13 ACETATE; ACETIC ACID DERIVATIVE; CALCIUM; CELL MARKER; FLUORESCENT DYE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FURA 2 ACETOXYMETHYL ESTER; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD RHEOLOGY; CALCIUM BLOOD LEVEL; CELL LABELING; CELL MEMBRANE FLUIDITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; INFLAMMATION; ISCHEMIA; LEUKOCYTE ACTIVATION; MALE; MEDICAL ASSESSMENT; NEUTROPHIL; STAGING;

ADULT; CALCIUM; CELL MEMBRANE; CYTOSOL; FLUORESCENT DYES; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE COUNT; MALE; MEMBRANE FLUIDITY; MYOCARDIAL INFARCTION; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHIL ACTIVATION; NEUTROPHILS; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS;

EID: 4143093590     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. G.D. Friedman, A.L. Klatsky and A.B. Siegelaub, The leukocyte count as a predictor of myocardial infarction, N. Engl. J. Med. 290 (1974), 1275-1278.
2. R.L. Prentice, T.P. Szatrowski, H. Kato and M.W. Mason, Leukocyte counts and cerebrovascular disease, J. Chronic Diseases 35 (1982), 703-714.
3. R.L. Prentice, T.P. Szatrowski, T. Fujikura, H. Kato, M.W. Mason and H.H. Hamilton, Leukocyte counts and coronary heart disease in a Japanese cohort, Am. J. Epidemiol. 116 (1982), 496-506.
4. P.J. Shoenfeld, Leucopenia and low incidence of myocardial infarction, Lancet 1 (1981), 1606.
5. J.B. Zalokar, J.L. Richards and J.R. Blaude, Leukocyte count, smoking and myocardial infarction, N. Engl. J. Med. 394 (1981), 465-468.
6. R.C. Schlant, S. Forman and J. Stamler, The natural history of coronary heart disease: Prognostic factors after recovery from myocardial infarction in 2789 men, Circulation 66 (1982), 401-414.
7. R.H. Grimm, J.D. Neaton and W. Ludwig, Prognostic importance of the white blood cell count for coronary, cancer and all-cause mortality, JAMA 254 (1985), 1932-1937.
8. G.D.O. Lowe, S.G. Machado, W.F. Krol, B.A. Barton and C.D. Forbes, White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction, Thromb. Haemost. 54 (1985), 700-703.
9. J.W.G. Yarnell, P.M. Sweetnam and P.C. Elwood, Haemostatic factors and ischaemic heart disease: The Caerphilly study, Brit. Heart J. 53 (1985), 483-487.
10. J.B. Kostis, D. Turkevich and J. Sharp, Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography, Am. J. Cardiol. 53 (1984), 997-999.
11. H. Kawaguchi, T. Mori, T. Kawano, S. Kono, J. Sasaki and K. Arakawa, Band neutrophil count and the presence and severity of coronary atherosclerosis, Am. Heart J. 132 (1996), 9-12.
12. C.P. Cannon, C.H. McCabe, R.G. Wilcox, J.H. Bentley and E. Braunwald, Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators, Am. J. Cardiol. 87 (2001), 636-639.
13. H.V. Barron, S.D. Harr, M.J. Radford, Y. Wang and H.M. Krumholz, The association between white blood cell count and acute myocardial infarction mortality in patients > 65 years of age: findings from the cooperative cardiovascular project, J. Am. Coll. Cardiol. 38 (2001), 1654-1661.
14. M.S. Sabatine, D.A. Morrow, C.P. Cannon, S.A. Murphy, L.A. Demopoulos, P.M. DiBattiste, C.H. McCabe, E. Braunwald and M. Gibson, Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes, J. Am. Coll. Cardiol. 40 (2002), 1761-1768.
15. J. Dormandy, G. Nash, A. Morris and P. Thomas, White cell rheology in acute clinical ischaemia, Clin. Hemorheol. 7 (1987), 509.
16. I. Juhan-Vague, M. Billerey, M. Buonocore, B. Rousset, C. Roul, M.F. Aillaud, J.L. Bouvier and A. Serradimigni, Decrease of white cell filtrability after myocardial infarction. Relationship with the size of the necrosis, Clin. Hemorheol. 7 (1987), 426.
17. R. Agosti, P. Ticozzelli, P. Fanari, S. Villa, F.S.O. Nasrawi and E. Longhini, Leukocyte filterability during the clinical course of acute myocardial and cerebral infarction, Clin. Hemorheol. 13 (1993), 13.
18. R. Bauersachs, G. Mossmer, F.-J. Neumann, I. Ott and C. Pfafferott, Rheology of white and red blood cells in coronary artery disease (CAD), Clin. Hemorheol. 13 (1993), 838.
19. F. Porro, L. Porretti, C. Arosio, P. Mancuso and G. Schinco, Filterability of red cells and white blood cells subpopulations in ischemic heart disease, Clin. Hemorheol. 15 (1995), 522.
20. G.B. Nash, B. Christopher, A.J.R. Morris and J.A. Dormandy, Changes in the flow properties of white blood cells after acute myocardial infarction, Br. Heart J. 62 (1989), 329-334.
21. M.E. Braun, A. Noe, W. Selinger, S. Haag, H. Haupt, H. Tillmanns and F.-J. Neumann, Prognostic significance of white cell count, neutrophil deformability and activation in unstable angina, Clin. Hemorheol. 9 (1989), 452.
22. G. Caimi, E. Hoffmann, M. Montana, B. Canino, F. Dispensa, A. Catania and R. Lo Presti, Haemorheological pattern in young adults with acute myocardial infarction, Clin. Hemorheol. Microcirc. 29 (2003), 11-18.
23. J. Mikita, G. Nash and J. Dormandy, A simple method of preparing white blood cells for filterability testing, Clin. Hemorheol. 6 (1986), 635-639.
24. S.E. Lennie, G.D.O. Lowe, J.C. Barbenel, C.D. Forbes and W.S. Foulds, Filterability of white blood cell subpopulations, separated by an improved method, Clin. Hemorheol. 7 (1987), 811-816.
25. M. Donner, S. Muller and J.F. Stoltz, Molecular rheology of white blood cells, Rev. Port. Hemorreol. 3 (1989), 235-247.
26. M. Donner and J.F. Stoltz, Comparative study on fluorescent probes distributed in human erythrocyte and platelet, Biorheology 22 (1985), 385-397.
27. M. Shinitzky and Y. Barenholtz, Fluidity parameters of lipids regions determined by fluorescence polarization, Biochim. Biophys. Acta 515 (1978), 367-394.
28. M.W. Roe, J.J. Lemasters and B. Herman, Assessment of Fura 2 for measurements of cytosolic free calcium, Cell Calcium 11 (1990), 63-73.
29. 2+-indicator fura-2, Cell Calcium 9 (1988), 167-179.
30. K. Yasui, M. Masuda, T. Matsuoka, M. Yamazaki, A. Komiyama, T. Akabane, M. Hasui, Y. Kobayashi and K. Murata, Abnormal membrane fluidity as a cause of impaired dynamics of chemoattractant receptors on neonatal polymorphonuclear leukocytes: lack of modulation of the receptors by a membrane fluidizer, Pediatr. Res. 24 (1988), 442-446.
31. M. Masuda, Y. Komiyama, T. Murakami, K. Murata, M. Hasui, Y. Hirabayashi and Y. Kobayashi, Difference in changes of membrane fluidity of polymorphonuclear leukocytes stimulated with phorbol myristate acetate and formyl-methionyl-leucyl-phenilalanine: role of excited oxygen species, J. Leukocyte Biol. 47 (1990), 105-110.
32. M.L. Entman and C.W. Smith, Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease, Cardiovasc. Res. 28 (1994), 1301-1311.
33. N.G. Frangogiannis, C.W. Smith and M.L. Entman, The inflammatory response in myocardial infarction, Cardiovasc. Res. 53 (2002), 31-47.
34. N.G. Frangogiannis, K.A. Youker, R.D. Rossen, M. Gwechenberger, M.H. Lindsey, L.H. Mendoza, L.H. Michael, C.M. Ballantyne, C.W. Smith and M.L. Entman, Cytokines and the microcirculation in ischemia and reperfusion, J. Mol. Cell Cardiol. 30 (1998), 2567-2576.
35. J.L. Mehta and D.Y. Li, Inflammation in ischemic heart disease: response to tissue injury or a pathogenetic villain?, Cardiovasc. Res. 43 (1999), 291-299.